Neuropace, Inc. NPCE Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s deferred tax assets?
- Neuropace, Inc. (NPCE) reported deferred tax assets of $46.03M in Q4 2025.
- How has Neuropace, Inc.'s deferred tax assets changed year-over-year?
- Neuropace, Inc.'s deferred tax assets increased by 9.5% year-over-year, from $42.04M to $46.03M.
- What is the long-term trend for Neuropace, Inc.'s deferred tax assets?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s deferred tax assets has grown at a 8.7% compound annual growth rate (CAGR), from $30.37M to $46.03M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.